[go: up one dir, main page]

ES2099293T3 - Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil. - Google Patents

Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil.

Info

Publication number
ES2099293T3
ES2099293T3 ES92925443T ES92925443T ES2099293T3 ES 2099293 T3 ES2099293 T3 ES 2099293T3 ES 92925443 T ES92925443 T ES 92925443T ES 92925443 T ES92925443 T ES 92925443T ES 2099293 T3 ES2099293 T3 ES 2099293T3
Authority
ES
Spain
Prior art keywords
erectile dysfunction
piridylguanidine
compounds
treatment
penis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92925443T
Other languages
English (en)
Inventor
Allen E Buhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2099293T3 publication Critical patent/ES2099293T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

UN METODO PARA INDUCIR O AUMENTAR UNA ERECCION O TRATAR LA DISFUNCION ERECTIL A TRAVES DE LA ADMINISTRACION DE UN COMPONENTE PIRIDILGUANIDINA, PREFERIBLEMENTE, N-CIANO-N (1,1-DIMETIL PROPIL)N -3-PIRIDINIL GUANIDINA, EN DOSIS PEQUEÑAS AL PENE. LA ADMINISTRACION PUEDE SER POR INYECCION DENTRO DEL CUERPO CAVERNOSO DEL PENE O APLICACION TRANSDERMAL.
ES92925443T 1991-12-23 1992-12-02 Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil. Expired - Lifetime ES2099293T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81670091A 1991-12-23 1991-12-23

Publications (1)

Publication Number Publication Date
ES2099293T3 true ES2099293T3 (es) 1997-05-16

Family

ID=25221384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92925443T Expired - Lifetime ES2099293T3 (es) 1991-12-23 1992-12-02 Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil.

Country Status (12)

Country Link
US (1) US5488059A (es)
EP (1) EP0618798B1 (es)
JP (1) JPH07506333A (es)
KR (1) KR940703666A (es)
AT (1) ATE149834T1 (es)
AU (1) AU661747B2 (es)
CA (1) CA2123312A1 (es)
DE (1) DE69218246T2 (es)
DK (1) DK0618798T3 (es)
ES (1) ES2099293T3 (es)
GR (1) GR3023448T3 (es)
WO (1) WO1993012788A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6436944B1 (en) * 1999-09-30 2002-08-20 Pfizer Inc. Combination effective for the treatment of impotence
KR20010076961A (ko) * 2000-01-29 2001-08-17 김제종 성기능장애 예방 및 치료용 약제
EP1917244A2 (de) 2005-08-24 2008-05-07 Abbott GmbH & Co. KG Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment

Also Published As

Publication number Publication date
KR940703666A (ko) 1994-12-12
GR3023448T3 (en) 1997-08-29
DK0618798T3 (da) 1997-09-22
WO1993012788A1 (en) 1993-07-08
CA2123312A1 (en) 1993-07-08
JPH07506333A (ja) 1995-07-13
EP0618798B1 (en) 1997-03-12
DE69218246D1 (de) 1997-04-17
ATE149834T1 (de) 1997-03-15
AU661747B2 (en) 1995-08-03
EP0618798A1 (en) 1994-10-12
AU3149793A (en) 1993-07-28
DE69218246T2 (de) 1997-07-17
US5488059A (en) 1996-01-30

Similar Documents

Publication Publication Date Title
CO5050298A1 (es) Metodo y composicion para tratar impotencia
AR002992A1 (es) Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.
SE8803087L (sv) Ett nytt saett foer behandling av erektil dysfunktion
ATE173603T1 (de) Behandlung von erektionversagen
EA200200324A1 (ru) Способы применения селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции
DK0480934T3 (da) Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
ES2099293T3 (es) Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil.
CO5580742A2 (es) Metodos y formas de dosificacion para la administracion con- trolada de paliperidona
MX9201439A (es) Dispositivo para reducir la sensacion durante el suministro iontoporetico de drogas.
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
ES2074490T3 (es) Procedimiento para la elaboracion de un preparado de inmunoglobulina g tolerable por via intravenosa.
BR9203277A (pt) Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
ES2059121T3 (es) Uso de agentes sensibilizantes de insulina para tratar la hipertension.
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
DE69229125D1 (de) Linderung oder vorbeugung des migräneanfalls mit mitteln zur hemmung der mastzellendegranulation
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
AR244073A1 (es) Dispositivo para el tratamiento de la disfuncion sexual masculina.
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
ES2168772T3 (es) Uso de hormona del crecimiento en composiciones para el tratamiento de la resistencia del corazon a la insulina.
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
RU96122371A (ru) Способ лечения эндогенных и послеоперационных увеитов
EA200000514A1 (ru) Способ лечения эректильной дисфункции

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 618798

Country of ref document: ES